poisar

Stocks · News reference

Merck KGaA Opens New Production Center in Daejeon, South Korea

Merck KGaA has officially inaugurated a new production center in the Dungok district of Daejeon, South Korea, to support its life science operations.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MRK
Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Keith Speights

    Could Revolution Medicines Be a Millionaire-Maker Stock?

    Revolution Medicines (RVMD) has surged over 9x in three years following FDA approval of its cancer drug Rasonque for pancreatic cancer treatment. While the stock has delivered impressive returns, analysts suggest it's unlikely to reach the $1.6 trillion market cap needed to turn a $25,000 investment into $1 million. However, with additional pipeline candidates and analyst support, the company could still generate market-beating returns for long-term investors.

    RVMDRVMDWLLYMRK
  2. Adria Cimino

    Will Moderna Soar on Nov. 6?

    Moderna stock has surged over 100% this year, driven by positive results from its personalized cancer vaccine candidate in combination with Merck's Keytruda. The company is scheduled to report Q3 earnings on Nov. 6, with investors focused on oncology progress and cancer vaccine development. While recent data leak caused a stock dip, the author expects the next major catalyst to come from fresh cancer vaccine data rather than the earnings report itself.

    MRNAMRKNVDAMU
  3. SEC EDGAR

    8-K filing — Merck & Co., Inc. (MRK)

    Filed: 2026-10-29 AccNo: 0001104659-26-119825 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

    MRK